We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

A new multi-omics approach finds risk genes beyond 13-gene panels, expanding detection in hereditary breast/ovarian cancer. More...
18 Aug 2026
Image: Graphical Abstract (Reko N, Torabi-Marashi A, Kallurkar P, et al.  The American Journal of Human Genetics, 2026. doi:10.1016/j.ajhg.2026.06.017)

Machine Learning Approach Expands Epigenetic Testing for Prenatal Genetic Disorders

A machine learning approach adapts blood-based epigenetic signatures for use across tissues, improving prenatal variant interpretation. More...
18 Aug 2026
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

A new handheld breath sensor detects SARS‑CoV‑2 from exhaled air with near‑instant, selective readouts. More...
18 Aug 2026
Image: Tempus becomes the second commercial laboratory partner in CellCarta’s CDx Commercialization Lab Network, contributing its oncology expertise to the company’s CDx Accelerator Model

Strategic Collaboration Expands Commercial Access to Oncology Companion Diagnostics

CellCarta announced a strategic collaboration with Tempus AI to broaden access to companion diagnostics (CDx) in oncology. More...
18 Aug 2026
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

New findings show leading plasma p-tau217 assays detect amyloid with varying accuracy, urging platform-specific calibration. More...
18 Aug 2026
Image: A phase object modeled as a thin, pure phase transmission mask is illuminated with horizontally polarized light at two different wavelengths (Haiwei Wang et al., Nanophotonics (2026). DOI: 10.1002/nap2.70190)

Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices

A new metasurface enables quantitative phase microscopy on compact sensors, enhancing label-free point-of-care imaging. More...
18 Aug 2026
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Early PSA-based mathematical markers help guide adaptive versus continuous prostate cancer therapy and predict progression. More...
17 Aug 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automatic CLIA Analyzer
Shine i6000
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Copyright © 2000-2026 Globetech Media. All rights reserved.